Literature DB >> 7809028

Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv.

M Whitlow1, D Filpula, M L Rollence, S L Feng, J F Wood.   

Abstract

Single-chain Fv proteins are known to aggregate and form multimeric species. We report here that these molecules represent a new class of molecular assembly, which we have termed multivalent Fvs. Each binding site in a multivalent Fv comprises the variable light-chain (VL) domain from a single-chain Fv, and the variable heavy-chain (VH) domain from a second single-chain Fv. Each single-chain Fv in a multivalent Fv is part of two binding sites. We have characterized the multivalent forms of the 4-4-20, CC49 and B6.2 sFvs. The degree of multivalent Fv formation is linker-dependent. Multivalent Fvs cannot form in the absence of an intact linker. Multivalent Fvs can be stabilized by their antigen. The conversion between different forms of the multivalent Fvs can be catalyzed by disassociating agents such as 0.5 M guanidine hydrochloride with 20% ethanol. Multivalent Fvs have significantly different stabilities depending on the specific variable domains from which they are constructed. Two models have been proposed for the structure of a multivalent Fv. We have tested each model by attempting to produce a heterodimer from the anti-fluorescein 4-4-20 and anti-tumor CC49 variable regions. We successfully produced a 4-4-20/CC49 heterodimer that comprises two mixed sFvs. The first mixed sFv is composed of the 4-4-20 VL domain, a 12 residue linker and the CC49 Vh domain. The second mixed sFv is composed of a CC49 VL domain, a 12 residue linker and the 4-4-20 VH domain. The 4-4-20/CC49 heterodimer bound both fluorescein and the tumor-associated glycoprotein-72 antigen. These results support a VH/VL 'rearrangement' model in which each variable domain of a multivalent Fv binding site comes from a different polypeptide chain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809028     DOI: 10.1093/protein/7.8.1017

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  18 in total

1.  Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

Authors:  Barbara E Power; Larissa Doughty; Deborah R Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

2.  Expression and purification strategies for the production of single-chain antibody and T-cell receptor fragments in E. coli.

Authors:  P E Molloy; B M Graham; P M Cupit; S D Grant; A J Porter; C Cunningham
Journal:  Mol Biotechnol       Date:  1995-12       Impact factor: 2.695

3.  Optimization of the crystallizability of a single-chain antibody fragment.

Authors:  Jana Škerlová; Vlastimil Král; Milan Fábry; Juraj Sedláček; Václav Veverka; Pavlína Rezáčová
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

4.  Amino-acid composition after loop deletion drives domain swapping.

Authors:  Neha Nandwani; Parag Surana; Jayant B Udgaonkar; Ranabir Das; Shachi Gosavi
Journal:  Protein Sci       Date:  2017-08-30       Impact factor: 6.725

5.  A fully human scFv phage display library for rapid antibody fragment reformatting.

Authors:  Keyu Li; Kirstin A Zettlitz; Julia Lipianskaya; Yu Zhou; James D Marks; Parag Mallick; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2015-05-19       Impact factor: 1.650

6.  ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).

Authors:  Tove Olafsen; Shannon J Sirk; David J Betting; Vania E Kenanova; Karl B Bauer; Waldemar Ladno; Andrew A Raubitschek; John M Timmerman; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2010-01-06       Impact factor: 1.650

7.  Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific ⁶⁴Cu-DOTA conjugation.

Authors:  Richard Tavaré; Wei H Wu; Kirstin A Zettlitz; Felix B Salazar; Katelyn E McCabe; James D Marks; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2014-08-04       Impact factor: 1.650

8.  Basis for selection of improved carbohydrate-binding single-chain antibodies from synthetic gene libraries.

Authors:  S J Deng; C R MacKenzie; T Hirama; R Brousseau; T L Lowary; N M Young; D R Bundle; S A Narang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3.

Authors:  X Y Pei; P Holliger; A G Murzin; R L Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 10.  In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL.

Authors:  Pouya Safarzadeh Kozani; Pooria Safarzadeh Kozani; Roddy S O'Connor
Journal:  Mol Cancer Ther       Date:  2021-04-26       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.